PMC10102936_01
Representative axial positron emission tomography/computed tomography
(PET/CT) images demonstrating the gallbladder mass (arrows, CT image on left
with corresponding PET image on right).
10.1177_2050313X231166773-fig1.jpg
PMC10102936_01_10.1177_2050313X231166773-fig1.jpg
fig1-2050313X231166773
This PET/CT scan demonstrated a decrease in the size of her lung mass and a 2 cm hypermetabolic polypoid mass in the GB (Figure 1) highly concerning for a primary GB carcinoma that was first seen on prior PET/CT.
Gross photograph of polypoid fundic gallbladder mass.
10.1177_2050313X231166773-fig2.jpg
PMC10102936_01_10.1177_2050313X231166773-fig2.jpg
fig2-2050313X231166773
The GB grossly demonstrated a polypoid fundic mass on the hepatic side of the GB wall, with focal discoloration of the overlying mucosa (Figure 2).
Hematoxylin & eosin (H&E) and immunohistochemical (IHC) stains of the
gallbladder mass. (a) Low-power H&E image showing adjacent normal
gallbladder mucosa and the hypercellular tumor with geographic necrosis
visible (20x). (b) High-power H&E image demonstrating vaguely organoid
cellular architecture, the cells show variable cytoplasm with frequent
mitoses and apoptosis (200x). (c) IHC stain for synaptophysin is diffusely
positive (20x). (d) IHC stain for Ki67 demonstrates a proliferative index of
approximately 80% (20x).
10.1177_2050313X231166773-fig3.jpg
PMC10102936_01_10.1177_2050313X231166773-fig3.jpg
fig3-2050313X231166773
Histologically, sections demonstrated a hypercellular tumor with areas of geographic necrosis the adjacent GB mucosa was unremarkable (Figure 3(a)). Cytologically, the cells demonstrated variable amounts of cytoplasm, with vesicular-granular chromatin, prominent nucleoli, frequent mitotic figures, apoptotic bodies, and pleomorphism (Figure 3(b)). TTF1; with a Ki67 proliferative index of approximately 80% (Figure 3(d)). The findings were most consistent with an LCNEC involving the GB.